Detalles de la búsqueda
1.
Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
Circulation;
149(9): 644-655, 2024 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883682
2.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
N Engl J Med;
385(18): 1643-1655, 2021 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449185
3.
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
Am Heart J;
264: 72-82, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279839
4.
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Eur Heart J;
43(13): 1307-1316, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617993
5.
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
Circulation;
144(15): 1196-1211, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455849
6.
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
Am Heart J;
246: 32-43, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990582
7.
The Allegra transcatheter heart valve: Short term results from a multicenter registry.
Catheter Cardiovasc Interv;
98(6): 1204-1209, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34137483
8.
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Catheter Cardiovasc Interv;
98(3): 503-510, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33029937
9.
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
Catheter Cardiovasc Interv;
97(5): 797-804, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198837
10.
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Cardiovasc Drugs Ther;
35(2): 309-320, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515411
11.
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
Circulation;
140(23): 1904-1916, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553204
12.
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
Lancet;
393(10175): 987-997, 2019 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30827782
13.
Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial.
Catheter Cardiovasc Interv;
95(2): 175-184, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033154
14.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J;
209: 97-105, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703644
15.
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.
Catheter Cardiovasc Interv;
94(7): 917-925, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30895706
16.
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
Catheter Cardiovasc Interv;
93(1): 64-70, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196572
17.
Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Catheter Cardiovasc Interv;
94(3): 342-347, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565371
18.
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
Circulation;
136(14): 1304-1314, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794001
19.
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
N Engl J Med;
373(21): 2038-47, 2015 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26466021
20.
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
Eur Heart J;
38(42): 3124-3134, 2017 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020367